|
TARS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.663300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.036580E-03 |
| Normal-vs-Stage2 |
9.325400E-01 |
| Normal-vs-Stage3 |
7.879100E-03 |
| Normal-vs-Stage4 |
3.857600E-01 |
| Stage1-vs-Stage2 |
1.368500E-02 |
| Stage1-vs-Stage3 |
9.130000E-01 |
| Stage1-vs-Stage4 |
3.720000E-01 |
| Stage2-vs-Stage3 |
4.118500E-02 |
| Stage2-vs-Stage4 |
4.260600E-01 |
| Stage3-vs-Stage4 |
3.820000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.399110E-03 |
| Normal-vs-AfricanAmerican |
9.843200E-01 |
| Normal-vs-Asian |
2.291400E-01 |
| Caucasian-vs-AfricanAmerican |
1.159380E-01 |
| Caucasian-vs-Asian |
3.546800E-01 |
| AfricanAmerican-vs-Asian |
3.956600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.940400E-02 |
| Normal-vs-Female |
2.675300E-03 |
| Male-vs-Female |
6.528200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.792800E-04 |
| Normal-vs-Age(41-60Yrs) |
5.582700E-03 |
| Normal-vs-Age(61-80Yrs) |
8.846400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.670400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.570200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.024140E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.893200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.788300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.582400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.519000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.875500E-02 |
| Classical-VS-Follicular |
3.993800E-01 |
| Classical-VS-Other |
2.401800E-01 |
| Classical-VS-Normal |
1.346020E-02 |
| Tall-VS-Follicular |
3.800400E-02 |
| Tall-VS-Other |
5.006000E-01 |
| Tall-VS-Normal |
1.121260E-03 |
| Follicular-VS-Other |
1.335210E-01 |
| Follicular-VS-Normal |
2.273000E-01 |
| Other-VS-Normal |
5.656200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.856390E-02 |
| Normal-vs-N1 |
5.229200E-04 |
| N0-vs-N1 |
3.349900E-02 |
|
|
